CG Oncology (CGON) Retained Earnings (2023 - 2026)
CG Oncology (CGON) posted Retained Earnings of $1.5 billion for Q1 2026, up 503.97% on a QoQ basis from -$379.0 million in Q4 2025, and up 706.56% year-over-year from $189.8 million in Q1 2025.
CG Oncology (CGON) Retained Earnings (2023 - 2026) Analysis & Trends
CG Oncology's Retained Earnings history runs 4 years deep, the most recent figure standing at $1.5 billion for Q1 2026.
- Quarterly Retained Earnings rose 706.56% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 706.56% YoY) and the FY2025 annual result came in at -$379.0 million, down 139.84% from the prior year.
- Retained Earnings was $1.5 billion for Q1 2026 at CG Oncology, up from -$379.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.5 billion in Q1 2026 and bottomed at -$379.0 million in Q4 2025.
- A 4-year average of $512.0 million and a median of $719.4 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 13804.56% — and 2025, when it plunged 139.84%.
- CG Oncology's Retained Earnings stood at $6.8 million in 2023, then jumped by 13804.56% to $951.4 million in 2024, then plunged by 139.84% to -$379.0 million in 2025, then jumped by 503.97% to $1.5 billion in 2026.
- Business Quant data shows CGON's Retained Earnings at $1.5 billion in Q1 2026, -$379.0 million in Q4 2025, and $1.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 1.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Bn |
| Dec 31, 2025 | -378.98 Mn |
| Sep 30, 2025 | 1.03 Bn |
| Jun 30, 2025 | 964.21 Mn |
| Mar 31, 2025 | -252.40 Mn |
| Dec 31, 2024 | 951.35 Mn |
| Sep 30, 2024 | 722.95 Mn |
| Jun 30, 2024 | -165.78 Mn |
| Mar 31, 2024 | 715.81 Mn |
| Dec 31, 2023 | 6.84 Mn |